Concepedia

Qingping Zeng

QZ

Statistics

Publications

26

Citations

2K

H-Index

19

Active since

1993

Affiliations

Fosun Pharma (China)(Current)

Newbury College

Ollscoil na Gaillimhe – University of Galway

Central South University

Second Xiangya Hospital of Central South University

Qingping Zeng is an author at Fosun Pharma (China) specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1993–2024

26

Publications

26

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma

Naoya Mimura, Mariateresa Fulciniti, Güllü Görgün et al. · Blood · 2012 · 431 citations · Full text

Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy

Susan E. Logue, Eoghan P. McGrath, Patricia A. Cleary et al. · Nature Communications · 2018 · 283 citations · Full text

Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer

Na Zhao, Jin Cao, Longyong Xu et al. · Journal of Clinical Investigation · 2018 · 254 citations · Full text

, , +14

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling

Xia Sheng, Hatice Zeynep Nenseth, Su Qu et al. · Nature Communications · 2019 · 228 citations · Full text

Structure and mechanism of action of the hydroxy–aryl–aldehyde class of IRE1 endoribonuclease inhibitors

Mário Sanches, Nicole M. Duffy, Manisha Talukdar et al. · Nature Communications · 2014 · 130 citations · Full text

, , +9

1–5 of 26